Patrick G Lyons1, Ashley Snyder2, Sarah Sokol3, Dana P Edelson2, Babak Mokhlesi4, Matthew M Churpek4. 1. Washington University School of Medicine, Department of Medicine, Division of Pulmonary and Critical Care Medicine, St. Louis, Missouri. 2. The University of Chicago Medicine, Department of Medicine, Section of Hospital Medicine, Chicago, Illinois. 3. The University of Chicago Medicine, Department of Pharmaceutical Services, Chicago, Illinois. 4. The University of Chicago Medicine, Department of Medicine, Section of Pulmonary and Critical Care Medicine, Chicago, Illinois.
Abstract
BACKGROUND: Opioids and benzodiazepines are frequently used in hospitals, but little is known about outcomes among ward patients receiving these medications. OBJECTIVE: To determine the association between opioid and benzodiazepine administration and clinical deterioration. DESIGN: Observational cohort study. SETTING: 500-bed academic urban tertiary-care hospital. PATIENTS: All adults hospitalized on the wards from November 2008 to January 2016 were included. Patients who were "comfort care" status, had tracheostomies, sickle-cell disease, and patients at risk for alcohol withdrawal or seizures were excluded. MEASUREMENTS: The primary outcome was the composite of intensive care unit transfer or ward cardiac arrest. Discrete-time survival analysis was used to calculate the odds of this outcome during exposed time periods compared to unexposed time periods with respect to the medications of interest, with adjustment for patient demographics, comorbidities, severity of illness, and pain score. RESULTS: In total, 120,518 admissions from 67,097 patients were included, with 67% of admissions involving opioids, and 21% involving benzodiazepines. After adjustment, each equivalent of 15 mg oral morphine was associated with a 1.9% increase in the odds of the primary outcome within 6 hours (odds ratio [OR], 1.019; 95% confidence interval [CI], 1.013-1.026; P < 0.001), and each 1 mg oral lorazepam equivalent was associated with a 29% increase in the odds of the composite outcome within 6 hours (OR, 1.29; CI, 1.16- 1.45; P < 0.001). CONCLUSION: Among ward patients, opioids were associated with increased risk for clinical deterioration in the 6 hours after administration. Benzodiazepines were associated with even higher risk. These results have implications for ward-monitoring strategies. Journal of Hospital Medicine 2017;12:428-434.
BACKGROUND: Opioids and benzodiazepines are frequently used in hospitals, but little is known about outcomes among ward patients receiving these medications. OBJECTIVE: To determine the association between opioid and benzodiazepine administration and clinical deterioration. DESIGN: Observational cohort study. SETTING: 500-bed academic urban tertiary-care hospital. PATIENTS: All adults hospitalized on the wards from November 2008 to January 2016 were included. Patients who were "comfort care" status, had tracheostomies, sickle-cell disease, and patients at risk for alcohol withdrawal or seizures were excluded. MEASUREMENTS: The primary outcome was the composite of intensive care unit transfer or ward cardiac arrest. Discrete-time survival analysis was used to calculate the odds of this outcome during exposed time periods compared to unexposed time periods with respect to the medications of interest, with adjustment for patient demographics, comorbidities, severity of illness, and pain score. RESULTS: In total, 120,518 admissions from 67,097 patients were included, with 67% of admissions involving opioids, and 21% involving benzodiazepines. After adjustment, each equivalent of 15 mg oral morphine was associated with a 1.9% increase in the odds of the primary outcome within 6 hours (odds ratio [OR], 1.019; 95% confidence interval [CI], 1.013-1.026; P < 0.001), and each 1 mg oral lorazepam equivalent was associated with a 29% increase in the odds of the composite outcome within 6 hours (OR, 1.29; CI, 1.16- 1.45; P < 0.001). CONCLUSION: Among ward patients, opioids were associated with increased risk for clinical deterioration in the 6 hours after administration. Benzodiazepines were associated with even higher risk. These results have implications for ward-monitoring strategies. Journal of Hospital Medicine 2017;12:428-434.
Authors: Robert D Gibbons; Naihua Duan; David Meltzer; Andrew Pope; Edward D Penhoet; Nancy N Dubler; Charles Francis; Barbara Gill; Eva Guinan; Maureen Henderson; Suzanne T Ildstad; Patricia A King; Manuel Martinez-Maldonado; George E McLain; Joseph Murray; Dorothy Nelkin; Mitchell W Spellman; Sarah Pitluck Journal: Biostatistics Date: 2003-04 Impact factor: 5.899
Authors: Melissa M Garrido; Holly G Prigerson; Joan D Penrod; Shatice C Jones; Kenneth S Boockvar Journal: Clin Ther Date: 2014-11-04 Impact factor: 3.393
Authors: Matthew M Churpek; Trevor C Yuen; Christopher Winslow; Ari A Robicsek; David O Meltzer; Robert D Gibbons; Dana P Edelson Journal: Am J Respir Crit Care Med Date: 2014-09-15 Impact factor: 21.405
Authors: M van den Boogaard; P Pickkers; A J C Slooter; M A Kuiper; P E Spronk; P H J van der Voort; J G van der Hoeven; R Donders; T van Achterberg; L Schoonhoven Journal: BMJ Date: 2012-02-09
Authors: Frank J Overdyk; Oonagh Dowling; Joseph Marino; Jiejing Qiu; Hung-Lun Chien; Mary Erslon; Neil Morrison; Brooke Harrison; Albert Dahan; Tong J Gan Journal: PLoS One Date: 2016-02-25 Impact factor: 3.240
Authors: Anthony G Doufas; Lu Tian; Kevin A Padrez; Puntarica Suwanprathes; James A Cardell; Holden T Maecker; Periklis Panousis Journal: PLoS One Date: 2013-01-29 Impact factor: 3.240
Authors: Shoshana J Herzig; Mihaela S Stefan; Penelope S Pekow; Meng-Shiou Shieh; William Soares; Karthik Raghunathan; Peter K Lindenauer Journal: J Gen Intern Med Date: 2019-11-14 Impact factor: 5.128
Authors: Christine Soong; Cheryl Ethier; Yuna Lee; Dalia Othman; Lisa Burry; Peter E Wu; Karen A Ng; John Matelski; Barbara Liu Journal: J Gen Intern Med Date: 2022-01-03 Impact factor: 6.473
Authors: Mina Attin; Simeon Abiola; Rijul Magu; Spencer Rosero; Michael Apostolakos; Christine M Groth; Robert Block; C D Joey Lin; Orna Intrator; Deborah Hurley; Kimberly Arcoleo Journal: Resusc Plus Date: 2020-10-09
Authors: Jinzhao Chen; Gaoyu Wu; Andrew Michelson; Zachary Vesoulis; Jennifer Bogner; John D Corrigan; Philip R O Payne; Fuhai Li Journal: JAMIA Open Date: 2020-04-26